Recent sexually transmitted disease prevention efforts and their implications for AIDS health education.
In the absence of a cure or vaccine for acquired immune deficiency syndrome (AIDS) educational and social marketing efforts to reduce the transmission of Human T-lymphotropic type III/lymphadenopathy-associated virus (HTLV-III/LAV) are currently our best hope for controlling the disease. Since 1983, the Centers for Disease Control (CDC) has funded a series of research studies to determine whether education efforts can successfully motivate the adoption of key behaviors relevant to the control of a variety of sexually transmitted diseases (STDs). Analysis of the first two studies which are now completed, and preliminary data from a third study, have documented dramatic changes in behavior, knowledge, and attitudes among clients in inner-city public health clinics. The authors describe the principles and underlying assumptions that have guided the design of their STD initiatives, drawing special attention to the implications for AIDS health education efforts.
D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control* / Q000635:transmission; D000293:Adolescent; D000328:Adult; D003275:Contraceptive Devices, Male; D005260:Female; D006069:Gonorrhea / Q000188:drug therapy / Q000517:prevention & control; D006266:Health Education / Q000379:methods*; D006716:Homosexuality; D006801:Humans; D008297:Male; D012306:Risk; D012749:Sexually Transmitted Diseases / Q000517:prevention & control*; D013752:Tetracycline / Q000627:therapeutic use; D014743:Videotape Recording
D013752:Tetracycline